Literature DB >> 2152984

Cutaneous angiosarcoma of the breast 7 years after lumpectomy and radiation therapy.

E Rubin1, W A Maddox, M T Mazur.   

Abstract

A case of angiosarcoma of the skin of the breast is described in a woman 7 years after a primary breast carcinoma was treated by means of lumpectomy and irradiation. On mammograms, the angiosarcoma showed redevelopment of skin thickening and increase in breast density. Clinically, the skin showed patchy discoloration. Although there is an established association of angiosarcoma with lymphedema and therapeutic irradiation, there have been few other reports of this rare complication of local therapy for breast carcinoma. Recognition of the mammographic and clinical manifestations may help in the earlier diagnosis of additional cases.

Entities:  

Mesh:

Year:  1990        PMID: 2152984     DOI: 10.1148/radiology.174.1.2152984

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Lymphangiosarcoma of mons pubis following radiotherapy for carcinoma cervix.

Authors:  Lavleen Singh; Renu Madan; Sandeep R Mathur; Ruma Ray
Journal:  J Obstet Gynaecol India       Date:  2013-04-04

2.  MRI findings of radiation-associated angiosarcoma of the breast (RAS).

Authors:  Sona A Chikarmane; Eva C Gombos; Jayender Jagadeesan; Chandrajit Raut; Jyothi P Jagannathan
Journal:  J Magn Reson Imaging       Date:  2014-12-15       Impact factor: 4.813

3.  Angiosarcoma of the skin overlying an irradiated breast.

Authors:  R A Badwe; A M Hanby; I S Fentiman; M A Chaudary
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

4.  Radiation-induced sarcoma of the breast: a systematic review.

Authors:  Grishma R Sheth; Lee D Cranmer; Benjamin D Smith; Lauren Grasso-Lebeau; Julie E Lang
Journal:  Oncologist       Date:  2012-02-14

5.  The risk of angiosarcoma following primary breast cancer.

Authors:  W Cozen; L Bernstein; F Wang; M F Press; T M Mack
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.